Abstract Title:

The prevalence of celiac disease in at-risk groups of children in the United States.

Abstract Source:

J Pediatr. 2000 Jan ;136(1):86-90. PMID: 10636980

Abstract Author(s):

I Hill, A Fasano, R Schwartz, D Counts, M Glock, K Horvath

Article Affiliation:

Pediatric Gastroenterology and Nutrition, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.

Abstract:

OBJECTIVE: In contrast to its prevalence in Europe, celiac disease (CD) is considered rare in the United States. We aimed to determine the prevalence of CD in children presenting with symptoms or conditions associated with CD.

STUDY DESIGN: Individuals aged 6 months to 20 years were screened for IgG and IgA antigliadin (AGA-IgG and AGA-IgA) and antiendomysium (EMA) antibodies. Those with only elevated AGA-IgG were screened for selective IgA deficiency. Patients with elevated EMA, or AGA-IgG elevation and selective IgA deficiency, were advised to undergo small intestinal biopsy.

RESULTS: A total of 1200 individuals were studied; 34 were EMA positive-26 (19 EMA positive) consented to biopsy and 21 had CD, giving a prevalence of 1 in 57 (21/1200). Including the 15 EMA positive patients who refused a biopsy, the prevalence of CD in this study could be as high as 1 in 33 (36/1200).

CONCLUSIONS: CD is not rare in the United States and may be as common as in Europe. AGA and EMA are useful for identifying patients who should undergo a small intestinal biopsy.

Pubmed Data : J Pediatr. 2000 Jan ;136(1):86-90. PMID: 10636980
Study Type : Human Study
Additional Links
Problem Substances : Gliadin : CK(2244) : AC(99)

Print Options

Login to Comment

Commenting is limited to Members only. If you are already a member, please login to post a comment. If you do not have a member account and would like to become a member, please click here to begin the process to become a member.